Literature DB >> 11442491

A cautionary tale: how to delete mouse haemopoietic stem cells with busulphan.

C Jopling1, M Rosendaal.   

Abstract

In this study treating mice with the 'correct' dose of busulphan did not necessarily destroy all haematopoietic stem cells. In certain circumstances host stem cells survived undetected and subsequently resumed haemopoiesis. This may apply to the use of busulphan clinically. We found that the following conditions determined the deletion of mouse stem cells using busulphan: (1) graft size--grafting more than 106 marrow cells ( approximately 0.3% of the animal's stem cells) concealed the survival of stem cells; (2) dose of busulphan--insufficient busulphan did not kill all host stem cells; (3) old or improperly stored busulphan failed to delete all host stem cells; furthermore (4) the survival of host stem cells should be assessed by typing many kinds of circulating cells; and (5) tests should be carried out to determine if busulphan has killed all host stem cells by typing circulating blood cells at appropriate intervals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11442491     DOI: 10.1046/j.1365-2141.2001.02825.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Accelerated ovarian aging in mice by treatment of busulfan and cyclophosphamide.

Authors:  Yan Jiang; Jing Zhao; Hui-jing Qi; Xiao-lin Li; Shi-rong Zhang; Daniel W Song; Chi-yang Yu; Jian-gang Gao
Journal:  J Zhejiang Univ Sci B       Date:  2013-04       Impact factor: 3.066

2.  Busulfan conditioning enhances engraftment of hematopoietic donor-derived cells in the brain compared with irradiation.

Authors:  Fiona L Wilkinson; Ana Sergijenko; Kia J Langford-Smith; Marcela Malinowska; Rob F Wynn; Brian W Bigger
Journal:  Mol Ther       Date:  2013-02-19       Impact factor: 11.454

3.  Serum FLT-3 ligand in a busulphan-induced model of chronic bone marrow hypoplasia in the female CD-1 mouse.

Authors:  Gemma Molyneux; Frances M Gibson; Matthew Whayman; John A Turton
Journal:  Int J Exp Pathol       Date:  2008-04       Impact factor: 1.925

4.  Conditioning with Fludarabine-Busulfan versus Busulfan-Cyclophosphamide Is Associated with Lower aGVHD and Higher Survival but More Extensive and Long Standing Bone Marrow Damage.

Authors:  Xin He; YongBin Ye; XiaoJun Xu; Jing Wang; YuXian Huang; GuangYang Weng; MingWan Zhang; KunYuan Guo
Journal:  Biomed Res Int       Date:  2016-10-24       Impact factor: 3.411

5.  Gosha-Jinki-Gan Recovers Spermatogenesis in Mice with Busulfan-Induced Aspermatogenesis.

Authors:  Ning Qu; Miyuki Kuramasu; Yoshie Hirayanagi; Kenta Nagahori; Shogo Hayashi; Yuki Ogawa; Hayato Terayama; Kaori Suyama; Munekazu Naito; Kou Sakabe; Masahiro Itoh
Journal:  Int J Mol Sci       Date:  2018-09-03       Impact factor: 5.923

6.  Use of Busulfan to Condition Mice for Bone Marrow Transplantation.

Authors:  Encarnacion Montecino-Rodriguez; Kenneth Dorshkind
Journal:  STAR Protoc       Date:  2020-11-06

7.  Signal one and two blockade are both critical for non-myeloablative murine HSCT across a major histocompatibility complex barrier.

Authors:  Kia J Langford-Smith; Zara Sandiford; Alex Langford-Smith; Fiona L Wilkinson; Simon A Jones; J Ed Wraith; Robert F Wynn; Brian W Bigger
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.